Results overview: Found 3 records in 0.02 seconds.
Articles, 3 records found
Articles 3 records found  
1.
15 p, 594.2 KB A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy : results from FIRE-3 and JACCRO 05 and 06 trials / Sebio, A. (Institut d'Investigació Biomèdica Sant Pau) ; Stintzing, S. (Department of Hematology and Oncology, Klinikum der Universitat, University of Munich,) ; Heinemann, V. (Department of Hematology and Oncology, Klinikum der Universitat, University of Munich,) ; Sunakawa, Y. (Keck School of Medicine, University of Southern California) ; Zhang, W. (Keck School of Medicine, University of Southern California) ; Ichikawa, W. (Division of Medical Oncology, Showa University) ; Tsuji, A. (Department of Clinical Oncology, Kagawa University) ; Takahashi, T. (Division of Medical Oncology, Showa University) ; Parek, A. (Keck School of Medicine, University of Southern California) ; Yang, D. (Keck School of Medicine, University of Southern California) ; Cao, S. (Keck School of Medicine, University of Southern California) ; Ning, Y. (Keck School of Medicine, University of Southern California) ; Stremitzer, S. (Keck School of Medicine, University of Southern California) ; Matsusaka, S. (Keck School of Medicine, University of Southern California) ; Okazaki, S. (Keck School of Medicine, University of Southern California) ; Barzi, A. (Keck School of Medicine, University of Southern California) ; Berger, M. (Keck School of Medicine, University of Southern California) ; Lenz, H-J (Keck School of Medicine, University of Southern California)
The Hippo pathway is involved in colorectal cancer (CRC) development and progression. The Hippo regulator Rassf1a is also involved in the Ras signaling cascade. In this work, we tested single nucleotide polymorphisms within Hippo components and their association with outcome in CRC patients treated with cetuximab. [...]
2016 - 10.1038/tpj.2016.69
The pharmacogenomics journal, october 2016  
2.
22 p, 644.2 KB Germline polymorphisms in genes involved in the Hippo pathway as recurrence biomarkers in stage II/III colon cancer / Sebio, Ana (Institut d'Investigació Biomèdica Sant Pau) ; Matsusaka, Satoshi (Keck School of Medicine, University of Southern California) ; Zhang, Wu (Keck School of Medicine, University of Southern California) ; Yang, Dongyun (Keck School of Medicine, University of Southern California) ; Ning, Yan (Keck School of Medicine, University of Southern California) ; Stremitzer, Stefan (Keck School of Medicine, University of Southern California) ; Stintzing, Sebastian (Department of Hematology and Oncology, Klinikum der Universitat, University of Munich, Munich, Germany) ; Sunakawa, Yu (Keck School of Medicine, University of Southern California) ; Yamauchi, Shinichi (Keck School of Medicine, University of Southern California) ; Fujimoto, Yoshiya (Cancer Institute Hospital. Department of Gastroenterological Surgery (Tokyo)) ; Ueno, Masashi (Cancer Institute Hospital. Department of Gastroenterological Surgery (Tokyo)) ; Lenz, Heinz-Josef (Keck School of Medicine, University of Southern California)
The Hippo pathway regulates tissue growth and cell fate. In colon cancer, Hippo pathway deregulation promotes cellular quiescence and resistance to 5-Fluorouracil. In this study 14 polymorphisms in 8 genes involved in the Hippo pathway (MST1, MST2, LATS1, LATS2, YAP, TAZ, FAT4 and RASSF1A) were evaluated as recurrence predictors in 194 patients with stages II/III colon cancer treated with 5-Fu-based adjuvant chemotherapy. [...]
2015 - 10.1038/tpj.2015.64
The pharmacogenomics journal, Vol. 16 (september 2015) , p. 312-319  
3.
13 p, 344.0 KB An international trial of quantitative PCR for monitoring Legionella in artificial water systems / Lee, JV (Health Protection Agency) ; Lai, S (Health Protection Agency) ; Exner, M (Institute for Universität Bonn. Hygiene and Public Health) ; Lenz, J (Institute for Universität Bonn. Hygiene and Public Health) ; Gaia, V (Istituto Cantonale di Microbiologia) ; Casati, S (Istituto Cantonale di Microbiologia) ; Hartemann, P (CHU Nancy) ; Lück, C (University of Technology. Institute of Medical Microbiology and Hygiene) ; Pangon, B (CH Versailles. Unité de Microbiologie-Hygiène) ; Ricci, ML (Istituto Superiore di Sanità) ; Scaturro, M (Istituto Superiore di Sanità) ; Fontana, S (Istituto Superiore di Sanità) ; Sabrià Leal, Miquel (Universitat Autònoma de Barcelona) ; Sánchez, Inma (Universitat Autònoma de Barcelona) ; Assaf, S (Pall GeneSystems) ; Surman-Lee, S (Health Protection Agency)
To perform an international trial to derive alert and action levels for the use of quantitative PCR (qPCR) in the monitoring of Legionella to determine the effectiveness of control measures against legionellae. [...]
2011 - 10.1111/j.1365-2672.2011.04957.x
Journal of Applied Microbiology, Vol. 110, Issue 4 (April 2011) , p. 1032-1044  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.